EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $198 | +1.0% | 12,566 | +24.8% | 0.02% | +9.1% |
| Q2 2023 | $196 | -2.0% | 10,066 | +42.5% | 0.02% | -8.3% |
| Q1 2023 | $200 | -99.9% | 7,066 | 0.0% | 0.02% | -7.7% |
| Q4 2022 | $206,539 | -23.5% | 7,066 | +16.5% | 0.03% | -23.5% |
| Q2 2022 | $270,000 | -16.9% | 6,066 | -7.6% | 0.03% | 0.0% |
| Q1 2022 | $325,000 | -2.7% | 6,566 | 0.0% | 0.03% | +3.0% |
| Q4 2021 | $334,000 | -8.7% | 6,566 | 0.0% | 0.03% | -15.4% |
| Q3 2021 | $366,000 | +30.2% | 6,566 | 0.0% | 0.04% | +34.5% |
| Q2 2021 | $281,000 | +51.9% | 6,566 | +65.6% | 0.03% | +26.1% |
| Q4 2020 | $185,000 | – | 3,966 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |